The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
A Randomised Trial To Control Sexually Transmitted Infections In Remote Aboriginal Communities.
Funder
National Health and Medical Research Council
Funding Amount
$1,847,403.00
Summary
This project will trial strategies for attaining clinical best practice in sexual health with an overall objective of reducing the high rates of sexually transmitted infection in remote Aboriginal communities in central and northern Australia. The trial will take place in 21 communities of which seven will be randomly assigned in each of the three years of the trial. This trial will determine whether strengthening primary health services can reduce the level of these infections.
The Physiology Of Health Systems: Port Lincoln As A Case Study
Funder
National Health and Medical Research Council
Funding Amount
$2,228,073.00
Summary
No health system in Australia has a complete, population-wide view of how they are used, by whom, and with what effect on health. Our plan is to capture and describe comprehensively all health system activity relating to a sizeable and carefully-defined Australian population and to complement this with a population-wide census of health status. Such 'intelligence' is fundamental to evaluating the current performance of health systems and to planning changes to them.
Discrimination Or Discretion? Factors Contributing To Discrimination Of People With Hepatitis C In Health Care Settings.
Funder
National Health and Medical Research Council
Funding Amount
$419,750.00
Summary
Hepatitis C is now the leading communicable disease in Australia and stigma and discrimination have been identified as major barriers to addressing this epidemic. This study builds on our previous work in which we have found evidence of discrimination against people with hepatitis C in health care settings. Discrimination, inappropriate and unfair treatment against people with hepatitis C, in health care settings is a major barrier to care, treatment and support. A key strategy for developing ef ....Hepatitis C is now the leading communicable disease in Australia and stigma and discrimination have been identified as major barriers to addressing this epidemic. This study builds on our previous work in which we have found evidence of discrimination against people with hepatitis C in health care settings. Discrimination, inappropriate and unfair treatment against people with hepatitis C, in health care settings is a major barrier to care, treatment and support. A key strategy for developing effective strategies to reduce both perceived and real discrimination of people with hepatitis C in health care settings is to gain a better understanding of the range of issues experienced by the health care providers themselves and factors in the broader health service context that impact on optimal care. The aim of this study is to identify these factors and the findings will influence policy and practice with the ultimate goal of removing barriers to equitable and appropriate health care for people with hepatitis C. The study will focus on both people (health care providers)- the knowledge, attitudes and practices among health care professionals in relation to infection control practices, hepatitis C and injecting drug use; and contexts (health care settings)- factors in the health care settings that contribute to discriminatory, inappropriate or unfair treatment of people with hepatitis C. The study will focus specifically on health care settings of general practice, dentistry, nursing and pharmacists. The outcomes will be used to develop practical and effective strategies for both improving health care for HCV positive individuals and improving the working relationships and environments for these health professionals working with this client population.Read moreRead less
Gudaga Project: Understanding The Health, Development, And Service Use Of Aboriginal Children In An Urban Environment
Funder
National Health and Medical Research Council
Funding Amount
$1,424,845.00
Summary
The Gudaga project is a birth cohort of Aboriginal children that will be followed from 18 months to 5 years and describe their health, development and service (health and children's) use. This is the first study of its kind in Eastern Australia. The research team are working closely with stakeholders in Aboriginal health care including the Aboriginal community to implement the research. The research will contribute to services for Aboriginal children in the local and wider community.
Development Of Quality Indicators For The Frail Elderly In Acute Care
Funder
National Health and Medical Research Council
Funding Amount
$372,311.00
Summary
Frail older people are particularly vulnerable to a range of mishaps while in hospital. Good care can reduce the frequency and extent of these problems. Quality indicators (QIs) assist hospitals, and clinical service units within them, to appraise their performance, and to compare it to other hospitals. QIs for the measurement of outcomes for the frail aged in the acute care setting do not exist in Australia or overseas. We aim to develop these indicators during this study.
IMPAKT: Improving Indigenous Patients' Access To Kidney Transplantation.
Funder
National Health and Medical Research Council
Funding Amount
$444,725.00
Summary
Indigenous Australians develop end-stage renal disease (ESRD) at up to thirty times the rate for non-Indigenous Australians. Almost a half of Indigenous ESRD patients come from remote regions without ESRD treatment services. People with end-stage renal disease (ESRD) need dialysis or a transplant to stay alive. Most patients from remote communities need to relocate to regional centres to receive haemodialysis. This causes profound isolation, significant community disruption and worsens survival. ....Indigenous Australians develop end-stage renal disease (ESRD) at up to thirty times the rate for non-Indigenous Australians. Almost a half of Indigenous ESRD patients come from remote regions without ESRD treatment services. People with end-stage renal disease (ESRD) need dialysis or a transplant to stay alive. Most patients from remote communities need to relocate to regional centres to receive haemodialysis. This causes profound isolation, significant community disruption and worsens survival. Transplantation is the best treatment for most people with ESRD. Compared with long-term dialysis, it is associated with a better quality of life, a longer life expectancy, and lower costs to the health-care system. Indigenous Australians are over-represented in the ESRD population, but have a significantly lower chance of receiving a transplant than non-indigenous Australians. In this research, the IMPAKT study, we aim to identify Indigenous Australians' barriers to access to renal transplantation for treatment of their ESRD, and to propose strategies to reduce disparities in Indigenous Australians' access to renal transplantation. The nephrologists who regulate access to renal transplantation in Australia are members of the research team. This should facilitate the translation of research findings into improved access to renal transplantation for Indigenous patients.Read moreRead less